Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $15.17B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: UNM stock price vs ANIP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ANIP's multiple
Needs ANIP P/E.
Implied fair value · at UNM's multiple
Needs UNM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: UNM FY 2025 (ended Dec 31, 2025) · ANIP FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 80% equity / 20% debt · EV / Revenue 1.44x · EV / EBITDA 20.12x
Capital structure 84% equity / 16% debt · EV / Revenue 1.84x · EV / EBITDA 7.53x
UNM carries the larger enterprise value at $18.78B against $1.63B; UNM trades on the lower EV / Revenue multiple (1.44x vs 1.84x); ANIP on the lower EV / EBITDA (7.53x vs 20.12x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Unum Group · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ANI PHARMACEUTICALS, INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.34x
0.57x
Net debt / EBITDA
Leverage against operating earnings
3.87x
0.11x
Cash and equivalents
Liquid reserves on the balance sheet
$158.20M
$285.59M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PRINCIPAL FINANCIAL GROUP INC
UNM vs PFG
LINCOLN NATIONAL CORP
UNM vs LNC
Cigna Group
UNM vs CI
AFLAC INC
UNM vs AFL
SUPERNUS PHARMACEUTICALS, INC.
UNM vs SUPN
PERRIGO Co plc
UNM vs PRGO
Viatris Inc
UNM vs VTRS
Organon & Co.
UNM vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
UNM vs TEVA
$3.77B
$309.11M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
